CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −331 | $152.04 | $50K | 136,205 |
| 2025-05-01 | Marcus Gail Boxer Director | Option exercise 10b5-1 | +4,000 | $24.42 | $98K | 13,704 |
| 2025-05-01 | Marcus Gail Boxer Director | Sale 10b5-1 | −31 | $146.34 | $5K | 13,673 |
| 2025-05-01 | Marcus Gail Boxer Director | Sale 10b5-1 | −323 | $147.95 | $48K | 13,350 |
| 2025-05-01 | Marcus Gail Boxer Director | Sale 10b5-1 | −241 | $149.05 | $36K | 13,109 |
| 2025-05-01 | Marcus Gail Boxer Director | Sale 10b5-1 | −341 | $149.96 | $51K | 12,768 |
| 2025-05-01 | Marcus Gail Boxer Director | Sale 10b5-1 | −672 | $151.37 | $102K | 12,096 |
| 2025-05-01 | Marcus Gail Boxer Director | Sale 10b5-1 | −942 | $152.22 | $143K | 11,154 |
| 2025-05-01 | Marcus Gail Boxer Director | Sale 10b5-1 | −1,450 | $153.06 | $222K | 9,704 |
| 2025-05-01 | Marcus Gail Boxer Director | Option exercise · Stock Option (right to buy) 10b5-1 | −4,000 | 4,299 | ||
| 2025-04-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −700 | $152.90 | $107K | 72,839 |
| 2025-04-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −700 | $153.94 | $108K | 72,139 |
| 2025-04-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,445 | $154.74 | $224K | 70,694 |
| 2025-04-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −200 | $155.44 | $31K | 70,494 |
| 2025-04-28 | Sheena Jonathan Director | Sale 10b5-1 | −439 | $152.18 | $67K | 254,914 |
| 2025-04-28 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −1,718 | $152.18 | $261K | 2,362,570 |
| 2025-04-28 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,993 | $152.18 | $303K | 223,674 |
| 2025-04-28 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −2,206 | $152.18 | $336K | 139,280 |
| 2025-04-28 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Gift 10b5-1 | −75 | 139,205 | ||
| 2025-04-28 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −1,709 | $152.18 | $260K | 155,237 |
Page 47 of 55 · 1,093 trades